AstraZeneca PLC Ordinary Shares (AZN)

Accounts Payable

$22.87B

Quarterly · Period ending: · USD

AZN logo

AZN Accounts Payable

Latest reported$22.87B
AZN Quarterly Accounts Payable ($625.70M → $22.87B)
High-resolution chart · PNG

AZN accounts payable history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

AstraZeneca PLC Ordinary Shares Accounts Payable — Quarterly (USD)
Period endingAccounts Payable (USD)
22,866,265,000
22,505,000,000
25,280,000,000
25,028,000,000
23,986,000,000
22,544,000,000
22,465,000,000
21,684,000,000
20,463,000,000
19,699,000,000
3,267,000,000
20,542,000,000
19,738,000,000
19,210,000,000
2,550,000,000
17,694,000,000
17,821,000,000
17,864,000,000
2,824,000,000
18,663,000,000
17,729,000,000
17,370,000,000
2,350,000,000
13,406,000,000
12,028,000,000
12,633,000,000
1,774,000,000
12,538,000,000
12,637,000,000
13,102,000,000
1,720,000,000
10,992,000,000
10,913,000,000
11,481,000,000
2,285,000,000
10,832,000,000
10,072,000,000
9,899,000,000
2,990,000,000
9,961,000,000
10,259,000,000
11,174,000,000
3,469,000,000
10,593,000,000
10,659,000,000
10,510,000,000
3,492,000,000
10,149,000,000
10,304,000,000
10,626,000,000
2,499,000,000
9,242,000,000
9,642,000,000
9,465,000,000
2,449,000,000
8,629,000,000
8,972,000,000
8,945,000,000
8,975,000,000
8,028,000,000
8,513,000,000
8,672,000,000
2,257,000,000
7,796,000,000
7,362,000,000
8,507,000,000
2,658,000,000
7,385,000,000
7,366,000,000
7,150,000,000
7,178,000,000
6,939,000,000
7,409,000,000
7,194,000,000
3,497,000,000
6,632,000,000
7,025,000,000
6,913,000,000
3,482,000,000
5,780,000,000
6,572,000,000
6,334,000,000
5,466,000,000
5,404,000,000
5,496,000,000
5,466,000,000
3,125,000,000
6,590,000,000
0
7,675,000,000
3,086,000,000
0
0
0
3,171,000,000
6,900,802,680
0
0
2,385,000,000
6,404,091,926
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.